ACADIA Pharmaceuticals Inc. ACAD
NASDAQ · United States · Health Technology
$19.65-0.50 (-2.48%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | 0.18 | 0.07 | +164.1% | $307.96M | +3.8% | +12.5%$25.61→$28.80 |
| Q1 2026 | 2026-05-06 | 0.02 | 0.08 | -75.0% | — | — | +0.9%$22.35→$22.56 |
| Q4 2025 | 2026-02-25 | 0.14 | 0.14 | 0.0% | — | — | +0.2%$24.59→$24.64 |
| Q3 2025 | 2025-11-05 | 0.42 | 0.15 | +180.0% | — | — | -0.9%$21.85→$21.65 |
| Q2 2025 | 2025-08-06 | 0.16 | 0.14 | +14.3% | — | — | — |
| Q1 2025 | 2025-05-07 | 0.11 | 0.11 | 0.0% | — | — | — |
| Q4 2024 | 2025-02-26 | 0.86 | 0.22 | +290.9% | — | — | — |
| Q3 2024 | 2024-11-06 | 0.20 | 0.14 | +42.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.